The electrostatic interactions of relaxin-3 with receptor RXFP4 and the influence of its B-chain C-terminal conformation

FEBS Journal

Volumn 281, Issue 13, 2014, Pages 2927-2936

  Wang, Xin Yi ^a,b   Guo, Yu Qi ^a   Zhang, Wei Jie ^a   Shao, Xiao Xia ^a   Liu, Ya Li ^b   Xu, Zeng Guang ^b   Guo, Zhan Yun ^a,b  

^a TONGJI UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

electrostatic interaction; mutagenesis; relaxin 3; relaxin family peptide; RXFP4

Indexed keywords

HORMONE RECEPTOR; RELAXIN 3; RELAXIN LIKE FAMILY PEPTIDE RECEPTOR 3; RELAXIN LIKE FAMILY PEPTIDE RECEPTOR 4; UNCLASSIFIED DRUG;

ALPHA HELIX; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN REFOLDING; RECEPTOR BINDING; RECEPTOR UPREGULATION; SITE DIRECTED MUTAGENESIS; STATIC ELECTRICITY;

ELECTROSTATIC INTERACTION; MUTAGENESIS; RELAXIN-3; RELAXIN-FAMILY PEPTIDE; RXFP4;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BINDING, COMPETITIVE; CONSERVED SEQUENCE; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RELAXIN;

EID: 84903766686     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12830     Document Type: Article

References (28)

1. Shabanpoor F, Separovic F, &, Wade JD, (2009) The human insulin superfamily of polypeptide hormones. Vitam Horm 80, 1-31.
2. Smith CM, Ryan PJ, Hosken IT, Ma S, &, Gundlach AL, (2011) Relaxin-3 systems in the brain-the first 10 years. J Chem Neuroanat 42, 262-275.
3. Tanaka M, (2010) Relaxin-3/insulin-like peptide 7, a neuropeptide involved in the stress response and food intake. FEBS J 277, 4990-4997.
4. Bathgate RA, Samuel CS, Burazin TC, Layfield S, Claasz AA, Reytomas IG, Dawson NF, Zhao C, Bond C, Summers RJ, et al,. (2002) Human relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene: novel members of the relaxin peptide family. J Biol Chem 277, 1148-1157.
5. Burazin TC, Bathgate RA, Macris M, Layfield S, Gundlach AL, &, Tregear GW, (2002) Restricted, but abundant, expression of the novel rat gene-3 (R3) relaxin in the dorsal tegmental region of brain. J Neurochem 82, 1553-1557.
6. Silvertown JD, Neschadim A, Liu HN, Shannon P, Walia JS, Kao JC, Robertson J, Summerlee AJ, &, Medin JA, (2010) Relaxin-3 and receptors in the human and rhesus brain and reproductive tissues. Regul Pept 159, 4-53.
7. Ma S, Sang Q, Lanciego JL, &, Gundlach AL, (2009) Localization of relaxin-3 in brain of Macaca fascicularis: identification of a nucleus incertus in primate. J Comp Neurol 517, 856-872.
8. Smith CM, Shen PJ, Banerjee A, Bonaventure P, Ma S, Bathgate RA, Sutton SW, &, Gundlach AL, (2010) Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brain. J Comp Neurol 518, 4016-4045.
9. Watanabe Y, Miyamoto Y, Matsuda T, &, Tanaka M, (2011) Relaxin-3/INSL7 regulates the stress-response system in the rat hypothalamus. J Mol Neurosci 43, 169-174.
10. Banerjee A, Shen PJ, Ma S, Bathgate RA, &, Gundlach AL, (2010) Swim stress excitation of nucleus incertus and rapid induction of relaxin-3 expression via CRF1 activation. Neuropharmacology 58, 145-155.
11. McGowan BM, Stanley SA, Smith KL, White NE, Connolly MM, Thompson EL, Gardiner JV, Murphy KG, Ghatei MA, &, Bloom SR, (2005) Central relaxin-3 administration causes hyperphagia in male Wistar rats. Endocrinology 146, 3295-3300.
12. McGowan BM, Stanley SA, White NE, Spangeus A, Patterson M, Thompson EL, Smith KL, Donovan J, Gardiner JV, Ghatei MA, et al,. (2007) Hypothalamic mapping of orexigenic action and Fos-like immunoreactivity following relaxin-3 administration in male Wistar rats. Am J Physiol Endocrinol Metab 292, E913-919.
13. McGowan BM, Stanley SA, Donovan J, Thompson EL, Patterson M, Semjonous NM, Gardiner JV, Murphy KG, Ghatei MA, et al,. (2008) Relaxin-3 stimulates the hypothalamic-pituitary-gonadal axis. Am J Physiol Endocrinol Metab 295, E278-286.
14. Smith CM, Hosken IT, Sutton SW, Lawrence AJ, &, Gundlach AL, (2012) Relaxin-3 null mutation mice display a circadian hypoactivity phenotype. Genes Brain Behav 11, 94-104.
15. Watanabe Y, Tsujimura A, Takao K, Nishi K, Ito Y, Yasuhara Y, Nakatomi Y, Yokoyama C, Fukui K, Miyakawa T, et al,. (2011) Relaxin-3-deficient mice showed slight alteration in anxiety-related behavior. Front Behav Neurosci 5, 50. doi: 10.3389/fnbeh.2011.00050.
16. Liu C, Eriste E, Sutton S, Chen J, Roland B, Kuei C, Farmer N, Jörnvall H, Sillard R, &, Lovenberg TW, (2003) Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135. J Biol Chem 278, 50754-50764.
17. Sudo S, Kumagai J, Nishi S, Layfield S, Ferraro T, Bathgate RA, &, Hsueh AJ, (2003) H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2. J Biol Chem 278, 7855-7862.
18. Liu C, Chen J, Sutton S, Roland B, Kuei C, Farmer N, Sillard R, &, Lovenberg TW, (2003) Identification of relaxin-3/INSL7 as a ligand for GPCR142. J Biol Chem 278, 50765-50770.
19. Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD, &, Hsueh AJ, (2002) Activation of orphan receptors by the hormone relaxin. Science 295, 671-674.
20. Liu C, Kuei C, Sutton S, Chen J, Bonaventure P, Wu J, Nepomuceno D, Kamme F, Tran DT, Zhu J, et al,. (2005) INSL5 is a high affinity specific agonist for GPCR142 (GPR100). J Biol Chem 280, 292-300.
21. Bathgate RA, Oh MH, Ling WJ, Kaas Q, Hossain MA, Gooley PR, &, Rosengren KJ, (2013) Elucidation of relaxin-3 binding interactions in the extracellular loops of RXFP3. Front Endocrinol (Lausanne) 4, 13. doi: 10.3389/fendo.2013.00013.
22. Zhang WJ, Wang XY, Guo YQ, Luo X, Gao XJ, Shao XX, Liu YL, Xu ZG, &, Guo ZY, (2014) The highly conserved negatively charged Glu141 and Asp145 of the G-protein-coupled receptor RXFP3 interact with the highly conserved positively charged arginine residues of relaxin-3. Amino Acids 46, 1393-1402.
23. Rosengren KJ, Lin F, Bathgate RA, Tregear GW, Daly NL, Wade JD, &, Craik DJ, (2006) Solution structure and novel insights into the determinants of the receptor specificity of human relaxin-3. J Biol Chem 281, 5845-5851.
24. Haugaard-Jonsson LM, Hossain MA, Daly NL, Craik DJ, Wade JD, &, Rosengren KJ, (2009) Structure of human insulin-like peptide 5 and characterization of conserved hydrogen bonds and electrostatic interactions within the relaxin framework. Biochem J 419, 619-627.
25. Zhang WJ, Luo X, Song G, Wang XY, Shao XX, &, Guo ZY, (2012) Design, recombinant expression and convenient A-chain N-terminal europium-labelling of a fully active human relaxin-3 analogue. FEBS J 279, 1505-1512.
26. Luo X, Liu YL, Layfield S, Shao XX, Bathgate RA, Wade JD, &, Guo ZY, (2010) A simple approach for the preparation of mature human relaxin-3. Peptides 31, 2083-2088.
27. Zhang WJ, Luo X, Liu YL, Shao XX, Wade JD, Bathgate RA, &, Guo ZY, (2012) Site-specific DOTA/europium-labeling of recombinant human relaxin-3 for receptor-ligand interaction studies. Amino Acids 43, 983-992.
28. Zhang WJ, Jiang Q, Wang XY, Song G, Shao XX, &, Guo ZY, (2013) A convenient method for europium-labeling of a recombinant chimeric relaxin family peptide R3/I5 for receptor-binding assays. J Pept Sci 19, 350-354.